Deutsche Balaton AG

Deutsche Balaton AG is a German private equity firm based in Heidelberg, focusing on investments in both listed and unlisted companies, real estate, and other assets. The company considers investments across various industries, with a tendency to invest in manufacturing, investment, and service sectors. It primarily targets companies in Germany and Hungary, employing exit strategies such as initial public offerings (IPOs) or trade sales.

Established in 1991, Deutsche Balaton AG is listed on the Hamburg Stock Exchange under the ticker symbol BBHK. As of 2024, the company reported revenues of €126.41 million and earnings of €96.21 million. The firm has a workforce of approximately 742 employees.

Some of the company's notable investments include Biofrontera (8% stake in biotechnology), Easy Software (11% stake in software), Epigenomics (6% stake in biotechnology), GK Software (6% stake in software), 4basebio (7% stake in pharmaceuticals), and Ultrasonic (7% stake in the footwear industry). Additionally, Deutsche Balaton AG holds an 88% indirect stake in Heidelberger Beteiligungsholding AG through its subsidiary, ABC Beteiligungen AG.

Deutsche Balaton AG's investment philosophy emphasizes strategic involvement in its portfolio companies, aiming to enhance value through active management and operational improvements. The firm's diverse portfolio reflects its commitment to fostering growth and development across various sectors and regions.